A new study has revealed that it's the fallout from a second wave of the dreaded Covid-19 pandemic which has overtaken work and money problems as the primary thing which scares most Russians, RT reports.
Every quarter, the Public Relations Development Company (CROS) analyzes Russia's mass media and social networks...
The Russian Direct Investment Fund (RDIF), which is backing the development and roll-out of Russia’s Sputnik V COVID-19 vaccine, said on Friday it had completed the pre-submission of preliminary documents to Brazil’s health regulator, Reuters reported.
The pre-submission, conducted together with RDIF’s local partners - the Brazilian state of Paraná...
Russian State Research Center of Virology and Biotechnology Vector has discovered more than 15 compounds with pronounced antiviral activity, which are promising for the creation of drugs for the treatment of the coronavirus infection, Russian public health watchdog Rospotrebnadzor said, as reported by Sputnik.
"To date, the antiviral properties of...
Last week, the developers of the world's first vaccine against coronavirus announced that the price of Sputnik V would be much lower than that of vaccines developed by U.S. pharmaceutical companies Pfizer and Moderna.
Russia plans to start mass vaccination against COVID-19 in 2021 and it will be voluntary, Deputy...
The measures taken to combat the COVID-19 pandemic in Russia ensure that no new restrictions are introduced so far, including a lockdown or interregional travel restrictions, Kremlin Spokesman Dmitry Peskov told reporters on Monday, commenting on the statement by Russian Health Minister Mikhail Murashko, who said that there may...
Russia will have supplied more than 1 million doses of its COVID-19 vaccine Sputnik V to its own national inoculation program by the end of this year, a government minister said on Wednesday, Reuters reports.
Russia, which began rolling out the vaccine in early December, has so far produced over...
A Russian lymphoma patient with long-term COVID-19 has acquired 18 mutations of the virus in over four months duration of the disease, according to the preprint of a study published at virological.org, Sputnik reports.
The study, released in early January, is authored by researchers from the Skolkovo Institute of Science...
The European Union’s top diplomat has said he hopes the Russian-developed coronavirus vaccine will be approved for use in the European bloc soon, The Moscow Times reported citing AFP.
Earlier this week, a peer-reviewed study published in The Lancet showed the Sputnik V vaccine to be 91.6% effective against symptomatic...
